Aberdeen Group’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-843
| Closed | -$269K | – | 969 |
|
|
2024
Q2 | $269K | Sell |
843
-27,369
| -97% | -$8.72M | ﹤0.01% | 904 |
|
|
2024
Q1 | $6.48M | Sell |
28,212
-64
| -0.2% | -$14.7K | 0.01% | 624 |
|
|
2023
Q4 | $6.22M | Buy |
+28,276
| New | +$6.22M | 0.01% | 634 |
|
|
2019
Q2 | – | Sell |
-44,730
| Closed | -$5.25M | – | 938 |
|
|
2019
Q1 | $5.25M | Hold |
44,730
| – | – | 0.01% | 622 |
|
|
2018
Q4 | $4.71M | Sell |
44,730
-24
| -0.1% | -$2.53K | 0.01% | 577 |
|
|
2018
Q3 | $5.72M | Buy |
44,754
+16,039
| +56% | +$2.05M | 0.01% | 598 |
|
|
2018
Q2 | $3.25M | Sell |
28,715
-5,068
| -15% | -$573K | 0.01% | 663 |
|
|
2018
Q1 | $3.8M | Sell |
33,783
-36,865
| -52% | -$4.14M | 0.01% | 591 |
|
|
2017
Q4 | $10.5M | Sell |
70,648
-786
| -1% | -$116K | 0.02% | 447 |
|
|
2017
Q3 | $8.37M | Buy |
+71,434
| New | +$8.37M | 0.02% | 478 |
|